1. Home
  2. TIL vs MIST Comparison

TIL vs MIST Comparison

Compare TIL & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

SELL

Current Price

$5.49

Market Cap

52.2M

Sector

Health Care

ML Signal

SELL

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$0.42

Market Cap

95.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIL
MIST
Founded
2018
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.2M
95.3M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
TIL
MIST
Price
$5.49
$0.42
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $3.86
AVG Volume (30 Days)
72.1K
★ 1.7M
Earning Date
11-16-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$215.89
Revenue Next Year
N/A
$157.01
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.28
$0.36
52 Week High
$13.50
$3.06

Technical Indicators

Market Signals
Indicator
TIL
MIST
Relative Strength Index (RSI) 31.93 30.08
Support Level N/A N/A
Resistance Level $7.67 $0.84
Average True Range (ATR) 0.49 0.08
MACD -0.08 -0.03
Stochastic Oscillator 17.13 12.36

Price Performance

Historical Comparison
TIL
MIST

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Share on Social Networks: